Please login to the form below

Not currently logged in
Email:
Password:

Bayer veteran joins Aurinia as CEO

Stephen Zaruby spent 20 years at German pharma company
Aurinia Stephen Zaruby

Aurinia Pharmaceuticals has appointed Stepen Zaruby as president and CEO.

His career includes a 20-year stint at German company Bayer, including spells managing its domestic and international anti-infectives, quinolone and hospital/surgical business franchises.

Mmost recently he served as president at ZymoGenetics until its acquisition by Bristol-Myers Squibb in 2010. Since then he has worked as an independent consultant in life sciences.

Commenting on his latest appointment, Zaruby said he was looking forward to the future for kidney-focused Aurinia as it looks to launch its first drug.

“Aurinia is well positioned to bring voclosporin forward as an important new treatment for lupus nephritis,” he said.

Aurinia's chair Dr Richard Glickman said: “Stephen is a seasoned leader with a strong track record of delivering strategic direction and operational excellence to both established and emerging life sciences companies.

“He is exceptionally qualified to help us build our voclosporin franchise and sharpen our execution."

11th November 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics